Posted on: September 11, 2012
Dr. Cantuaria, MD, PhD, medical director of Northside Hospital’s NCI Community Cancer Centers Program (NCCCP), has been nominated by his peers to co-chair the Program’s national clinical trials subcommittee. This prestigious honor will allow Dr. Cantuaria to develop, initiate and conduct innovative clinical trials that will benefit patients both nationally and here in Atlanta.
The NCCCP is a collaborative network of community hospitals working to: expand cancer research, enhance access to cancer care, and improve the quality of care for cancer patients served by community hospitals in urban, suburban and rural areas, with an emphasis on underserved populations. The network serves approximately 53,000 new cancer cases each year. A member of the NCCCP since 2010, Northside is one of only 21 sites nationwide and the only hospital in Metro Atlanta to have this honor.
The clinical trials subcommittee aims to advance research into new cancer treatments by involving more patients in clinical trials, providing them the opportunity to benefit from the latest therapies before they are available to the general patient population. NCCCP sites are building their capacities to offer earlier phase trials, which could reduce the need for patients to travel to urban, academic centers. Each site has a strong focus placed on reaching underserved populations, including minorities, the elderly, and those in both urban and rural communities.
Dr. Cantuaria’s role as Northside’s NCCCP medical director and principal investigator is a vital component that provides oversight of the activities of the hospital’s Cancer Institute, including clinical management, community outreach and disparities, clinical trials, information technology, biospecimen initiatives, quality of patient care, and survivorship and palliative care.
“It is a huge honor to have been elected by my peers to co-chair this clinical trials initiative,” said Dr. Cantuaria. “Through research, we can expand the understanding, diagnosis, treatment and prevention of disease, ensuring that patients have access to cutting-edge care, often in circumstances where conventional care fails them.”
Dr. Cantuaria is joined as co-chair of the clinical trials subcommittee by Edward Gorak, DO, MS, FACP, of Geisinger Health System in Danville, PA. Dr. Cantuaria joined Northside in 2011 and is among the most distinguished and experienced robotic gynecologic cancer surgeons in the country, specializing in the da Vinci Surgical System. He is an active member of several key professional societies including: the Society of Gynecologic Oncology, the International Gynecologic Cancer Society, the Brazilian Society of Obstetrics and Gynecology, and the American College of Obstetrics and Gynecology.
Read more about Northside Hospital’s Cancer Institute.
Filed under: Employees & Physicians,